Quantitation of zimelidine and norzimelidine in plasma using high-performance liquid chromatography.
A method is described for the quantitation of new non-tricyclic antidepressant, zimelidine, and its pharmacologically active, N-demethylated metabolite, norzimelidine, in plasma. The method involves a single extraction of basified plasma with diethyl ether, concentration of the ethereal extract, chromatography on a high-performance liquid chromatograph and quantitation using a variable-wavelength UV detector. The respective geometric isomers of zimelidene and norzimelidine are used as internal standards for quantitation. Resolution is effected using a 5-micron silica gel column with an aqueous methanolic solution of ammonium nitrate as the mobile phase. The minimum quantitated amount was 25 ng and the coefficient of variation for the method did not exceed 7% in the range 25 to 1000 ng/ml for both compounds. The method has been applied in monitoring the plasma concentration of zimelidine and norzimelidine in plasma from depressed patients and an example of this application is presented.
D000928:Antidepressive Agents / Q000097:blood*; D001969:Bromobenzenes / Q000097:blood*; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007536:Isomerism; D011725:Pyridines / Q000097:blood*; D015031:Zimeldine / Q000031:analogs & derivatives
D000928:Antidepressive Agents; D001969:Bromobenzenes; D011725:Pyridines; D015031:Zimeldine; C017578:norzimelidine